Cleared Special

8F Modified Sheath System (K240529) - FDA 510(k) Clearance

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K240529 · Route 92 Medical, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
222d
Days
Class 2
Risk

K240529 is an FDA 510(k) clearance for the 8F Modified Sheath System. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Route 92 Medical, Inc. (San Mateo, US). The FDA issued a Cleared decision on October 2, 2024 after a review of 222 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Route 92 Medical, Inc. devices

Submission Details

510(k) Number K240529 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 23, 2024
Decision Date October 02, 2024
Days to Decision 222 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d slower than avg
Panel avg: 148d · This submission: 222d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K240529.
Neurovascular Access System Family
K240746 · Q'Apel Medical, Inc. · Nov 2024
Zipline Access Catheter
K240711 · Perfuze, Ltd. · Oct 2024
CEREGLIDE 42 Intermediate Catheter
K241244 · Cerenovus, Inc. · Oct 2024
Next Generation Access Catheter
K234074 · Balt USA, LLC · Jul 2024
TracStar LDP Large Distal Platform
K240948 · Imperative Care, Inc. · Jun 2024
Wedge XL Delivery Catheter
K232542 · MicroVention, Inc. · May 2024